| Literature DB >> 34469846 |
Leigh A Kotze1, Vinzeigh N Leukes1, Zhuo Fang1, Manfred B Lutz2, Bryna L Fitzgerald3, John Belisle3, Andre G Loxton1, Gerhard Walzl1, Nelita du Plessis4.
Abstract
Myeloid-derived suppressor cells (MDSC) are induced during active TB disease to restore immune homeostasis but instead exacerbate disease outcome due to chronic inflammation. Autophagy, in conventional phagocytes, ensures successful clearance of M.tb. However, autophagy has been demonstrated to induce prolonged MDSC survival. Here we investigate the relationship between autophagy mediators and MDSC in the context of active TB disease and during anti-TB therapy. We demonstrate a significant increase in MDSC frequencies in untreated active TB cases with these MDSC expressing TLR4 and significantly more mTOR and IL-6 than healthy controls, with mTOR levels decreasing during anti-TB therapy. Finally, we show that HMGB1 serum concentrations decrease in parallel with mTOR. These findings suggest a complex interplay between MDSC and autophagic mediators, potentially dependent on cellular localisation and M.tb infection state.Entities:
Keywords: Autophagy; High mobility group box protein 1; Mycobacterium tuberculosis; Myeloid-derived suppressor cells; Tuberculosis
Mesh:
Substances:
Year: 2021 PMID: 34469846 PMCID: PMC9278564 DOI: 10.1016/j.cellimm.2021.104426
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.178